Skip to main content
INNOVA CAPTAB LIMITED logo

INNOVA CAPTAB LIMITED — Investor Relations & Filings

Ticker · INNOVACAP ISIN · INE0DUT01020 LEI · 549300SNL5HFUHE66804 BSE.NS Manufacturing
Open in API
Filings indexed 212 across all filing types
Latest filing 2026-02-02 Call Transcript
Country IN India
Listing BSE.NS INNOVACAP

About INNOVA CAPTAB LIMITED

https://www.innovacaptab.com

Innova Captab Limited is an integrated pharmaceutical company focused on the research, development, manufacturing, and marketing of a wide range of pharmaceutical formulations. The company operates primarily as a Contract Development and Manufacturing Organization (CDMO), providing comprehensive services to leading domestic and international pharmaceutical brands. Its product portfolio includes diverse dosage forms such as tablets, capsules, dry syrups, ointments, and injections across multiple therapeutic areas, including anti-infectives, analgesics, and gastrointestinal treatments. Innova Captab maintains a strong emphasis on R&D and quality control, operating advanced manufacturing facilities that adhere to global regulatory standards. In addition to its CDMO business, the company manages a domestic branded generics division and an international export business, catering to a global clientele with a focus on high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call held by Innova Captab Limited on January 27, 2026, discussing the financial and operational performance for the quarter and nine months ended December 31, 2025. It includes management commentary, financial highlights, business updates, and a Q&A session with analysts. The presence of detailed financial figures, discussion of revenue, EBITDA, PAT, business segments, and future outlook confirms this is a full earnings call transcript rather than a brief earnings release or summary. The document is about 15,000 characters long, indicating it is a substantive transcript rather than a short announcement or report publication notice. Therefore, the appropriate classification is Call Transcript (CT).
2026-02-02 English
Updates
Notice of Dividend Amount Classification · 95% confidence The document is a communication addressed to stock exchanges and shareholders regarding the deduction of tax at source (TDS) on an interim dividend declared for the financial year 2025-26. It includes details about the dividend declaration, tax implications, and instructions for shareholders to submit relevant documents. The document does not contain financial statements or detailed financial analysis but is an announcement related to dividend payment and tax deduction procedures. It is not a full financial report, earnings release, or regulatory certification. The content fits best under a Notice of Dividend Amount (DIV) as it announces the interim dividend amount, payment details, and related tax information to shareholders.
2026-01-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding the availability of an audio recording of an earnings call for the quarter and nine months ended 31st December 2025. It references an earnings call and provides a link to the audio recording but does not contain the transcript or detailed financial data itself. The document length is short (1824 characters), and it serves as an announcement or intimation about the earnings call recording rather than the call transcript or financial report itself. According to the classification rules, such a document is best classified as a Regulatory Filing (RNS) because it is an announcement related to the earnings call but does not contain the full transcript or substantive financial data. It is not a Call Transcript (CT) or Earnings Release (ER) because it only provides information about the availability of the audio recording, not the content of the call or financial highlights.
2026-01-27 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter from Innova Captab Limited addressed to stock exchanges (BSE and NSE) dated 24th January 2026. It informs about the Board of Directors' approval of the Un-audited (Standalone and Consolidated) Financial Results for the quarter and nine months ended 31st December 2025. The letter encloses a newspaper advertisement extract published on 24th January 2026 as per SEBI regulations. The content is primarily an announcement of the financial results approval and publication of the newspaper advertisement, not the full financial report itself. The document length is about 15,000 characters, but the main content is a notification and submission of an advertisement extract, not the detailed financial statements or analysis. Therefore, this is an announcement related to financial results publication, not the results report itself. According to the classification rules, such documents are best classified as Regulatory Filings (RNS) because they are announcements and notifications related to regulatory compliance and disclosures, not the full financial report or earnings release.
2026-01-24 English
Investor Presentation
Investor Presentation Classification · 100% confidence The document is an investor presentation dated 23rd January 2026 from Innova Captab Limited. It is addressed to stock exchanges and mentions an upcoming earnings call for the quarter and nine months ended 31st December 2025. The document includes detailed financial highlights, business overview, strategic initiatives, and performance commentary. It explicitly states it is an "Investor Presentation" and is provided pursuant to a regulatory requirement. The content is typical of an investor presentation focusing on financials, strategy, and market position rather than a full annual or quarterly report or earnings release. The length (15,000 characters) and detailed content confirm it is not a brief announcement or a certification. Therefore, the correct classification is Investor Presentation (IP).
2026-01-23 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release dated January 23, 2026, announcing the unaudited financial results for the quarter and nine months ended December 31, 2025. It includes detailed financial performance data such as revenue, EBITDA, and PAT for Q3 FY26 and 9M FY26, along with year-over-year growth comparisons. The document is addressed to stock exchanges and references compliance with SEBI regulations. It is not a full annual or interim report but a public announcement of quarterly financial results with key highlights and management commentary. The length (6538 characters) and content indicate it is more than a brief summary but does not contain full financial statements or comprehensive analysis typical of an Interim/Quarterly Report (IR). Instead, it fits the definition of an Earnings Release (ER), which is the initial announcement of quarterly/periodical financial results with key highlights only. 9M 2026
2026-01-23 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.